AI Help for Dentists › Tools › Pearl Second Opinion

Pearl Second Opinion: when the operatory screen shows the finding before you say a word

Our own short explainer — what the tool is built to do, then the process step by step. Pearl Second Opinion is FDA-cleared AI that detects pathology on dental radiographs in real time, chairside. Pricing is by quote; third-party reported around $299/mo per location plus ~$1,500 setup.

The short version:

• What it is: real-time AI detection of radiographic pathology, running chairside during the appointment — and it carries FDA clearance.
• Why practices buy it: the patient sees the flagged finding on screen at the same moment the dentist does, which changes the texture of the treatment conversation.
• Price reality: by quote. Third-party reporting points to ~$299/mo per location plus ~$1,500 setup; neither figure is vendor-published.
• Where it isn't the answer: if you want payer-side claims perspective, look at Overjet; if you want a published from-price, look at Denti.AI.

What is Second Opinion, and what does “real-time” actually mean here?

Most software that analyzes dental radiographs works on a review cycle: images go in, annotated results come back, someone looks at them between patients or at the end of the day. Second Opinion collapses that cycle into the appointment itself. The AI evaluates the radiograph as it's taken and paints its detections onto the image on the operatory monitor — while the patient is still in the chair and the dentist is still in the room.

The clinical framing is right there in the name. It isn't positioned as the diagnostician; it's positioned as the colleague who glances over your shoulder at the film and says “did you see that?” The dentist reads the image the way they always have, with a second set of algorithmic eyes catching what a tired human read might miss on the fourth hygiene check of the morning. The dentist confirms or dismisses every flag; nothing goes into the chart on the AI's authority alone.

For how this product category works in general — what these systems detect, where they fail, what to ask in a demo — start with our AI X-ray analysis guide.

Does the FDA clearance matter in practice?

Yes, and for two different audiences. For you, clearance means the detection claims have been through a regulatory process rather than resting entirely on marketing copy — though you should still pull the clearance record yourself and read what it actually covers, because clearance is scoped to specific uses. For your patients, “this screening software is FDA-cleared” is a sentence a front desk can say out loud without a lawyer wincing.

In this directory, Pearl's Second Opinion and Denti.AI's Detect are the two radiograph tools we describe as FDA-cleared. Whatever vendor you evaluate, verify current clearance status independently — our compliance guide explains how and why.

What changes when the patient watches the screen find it?

Every dentist has lived the trust gap: you point at a grey smudge on a radiograph, the patient nods politely, and you can tell they're weighing whether the crown is real or a boat payment. It isn't cynicism, exactly — it's that a verbal interpretation of an image they can't read asks them to take everything on faith.

A live, annotated screen shifts that dynamic. The software marks the area before the dentist has framed a recommendation, so the sequence the patient experiences is: image appears, machine flags region, dentist examines and explains. The finding stops being something the dentist asserted and becomes something the room discovered together. Practices call this co-diagnosis, and it's the honest core of Pearl's pitch — not that the AI finds what the dentist couldn't, but that the patient believes it faster when they watched it surface.

Two cautions worth stating plainly. First, we have no verified data tying Second Opinion to a specific case-acceptance percentage, and we won't manufacture one; treat any such number in a sales deck as a question to interrogate. Second, the AI will sometimes flag things the dentist rules out — decide in advance how your team narrates a dismissed flag, because “the computer was wrong” is also a sentence the patient will remember.

What does Pearl cost a practice?

Pearl sells by quote, so the number on your contract will come from a sales conversation. Third-party reported figures — useful for orientation, not for budgeting — put Second Opinion at roughly $299 per month per location with about $1,500 in one-time setup. Multi-location groups should model the per-location math before the call and ask directly how volume changes it.

Questions worth putting in writing: what the setup fee actually covers, whether imaging-sensor or software compatibility adds cost, the contract length, and what happens to the price at renewal. For scale: Overjet is also quote-only with a wider third-party reported band (~$250–$1,500/mo), while Denti.AI publishes Detect at $49/mo per location — a useful anchor to hold in your head during any quote conversation.

Pearl pricing is by quote. The ~$299/mo per location and ~$1,500 setup figures are third-party reported, not vendor-published; checked 2026-07-12. Confirm directly with the vendor.

What are the HIPAA and compliance basics?

Because Second Opinion runs during live appointments, also think through the operatory logistics: which monitors display AI annotations, whether flagged-then-dismissed findings are recorded in the chart, and how your team documents the dentist's confirmation. A written one-page protocol before go-live saves the awkward improvisation later. The fuller checklist lives in our dental AI HIPAA guide.

Who is Pearl right for?

Choosing between the two big radiograph AIs? Overjet vs Pearl puts them side by side, and the dental AI software comparison covers the whole field.

Common questions

Sources

Pearl — Second Opinion — pricing is by quote; the ~$299/mo per location and ~$1,500 setup figures cited here are third-party reported, not vendor-published, checked 2026-07-12. Re-verify with the vendor before budgeting. Last reviewed: 2026-07-12.